{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:57:37Z","timestamp":1785326257750,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jceh.2022.08.003","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T19:56:21Z","timestamp":1660420581000},"page":"319-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Palliative Care for Patients with End-Stage Liver Disease"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9587-336X","authenticated-orcid":false,"given":"Cyriac A.","family":"Philips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7239-0293","authenticated-orcid":false,"given":"Chandan K.","family":"Kedarisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2022.08.003_bib1","article-title":"Baveno VII - renewing consensus in portal hypertension","author":"Franchis","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jceh.2022.08.003_bib2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/hepr.13678","article-title":"Evidence-based clinical practice guidelines for liver cirrhosis 2020","volume":"51","author":"Yoshiji","year":"2021","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2022.08.003_bib3","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.3748\/wjg.v22.i18.4438","article-title":"Liver transplantation: current status and challenges","volume":"22","author":"Jadlowiec","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.08.003_bib4","series-title":"StatPearls [Internet]. Treasure Island (FL)","article-title":"Palliative care","author":"Teoli","year":"2022"},{"key":"10.1016\/j.jceh.2022.08.003_bib5","first-page":"359","article-title":"Hospice and palliative care: an overview","volume":"104","author":"Tatum","year":"2020","journal-title":"Med Clin"},{"key":"10.1016\/j.jceh.2022.08.003_bib6","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","article-title":"Prognostic indicators of survival in patients with compensated and decompensated cirrhosis","volume":"32","author":"Zipprich","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.08.003_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13613-017-0257-6","article-title":"Long-term outcome of patients with liver cirrhosis admitted to a general intensive care unit","volume":"7","author":"Warren","year":"2017","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jceh.2022.08.003_bib8","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/lt.25193","article-title":"Palliative care in end-stage liver disease: time to do better?","volume":"24","author":"Mazzarelli","year":"2018","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.08.003_bib9","series-title":"StatPearls [Internet]","article-title":"Use of child pugh score in liver disease","author":"Tsoris","year":"2022"},{"key":"10.1016\/j.jceh.2022.08.003_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.08.003_bib11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"Advanced liver disease study group. The model for end-stage liver disease (MELD)","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.08.003_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3350\/cmh.2013.19.2.105","article-title":"Important predictor of mortality in patients with end-stage liver disease","volume":"19","author":"Kim","year":"2013","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2022.08.003_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-230X-9-72","article-title":"Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation","volume":"9","author":"Gotthardt","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2022.08.003_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/gastro\/gou075","article-title":"Change in model for end-stage liver disease score at two weeks, as an indicator of mortality or liver transplantation at 60 days in acute-on-chronic liver failure","volume":"3","author":"Kumar","year":"2015","journal-title":"Gastroenterol Rep (Oxf)."},{"key":"10.1016\/j.jceh.2022.08.003_bib15","article-title":"MELD-Na accurately predicts 6-month mortality in patients with decompensated cirrhosis: potential trigger for hospice referral","author":"Brown","year":"2021","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2022.08.003_bib16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep4.1688","article-title":"Assessment of the frail patient with end-stage liver disease: a practical overview of sarcopenia, physical function, and disability","volume":"5","author":"Williams","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2022.08.003_bib17","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/liv.13917","article-title":"Frailty in advanced liver disease","volume":"38","author":"Laube","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.08.003_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100327","article-title":"Frailty and reduced gait speed are independently related to mortality of cirrhotic patients in long-term follow-up","volume":"25","author":"Soto","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jceh.2022.08.003_bib19","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jamasurg.2019.2845","article-title":"Association between liver transplant wait-list mortality and frailty based on body mass index","volume":"154","author":"Haugen","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jceh.2022.08.003_bib20","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jhep.2020.11.047","article-title":"Acute-on-chronic liver failure: a distinct clinical syndrome","volume":"75","author":"Moreau","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.08.003_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/flgastro-2016-100734","article-title":"Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention","volume":"8","author":"Hudson","year":"2017","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.jceh.2022.08.003_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.cgh.2013.08.027","article-title":"Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management","volume":"12","author":"Poonja","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.08.003_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.2016.8474","article-title":"Effect of palliative care-led meetings for families of patients with chronic critical illness: a randomized clinical trial","volume":"316","author":"Carson","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2022.08.003_bib24","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.cgh.2017.01.030","article-title":"Palliative care and health care utilization for patients with end-stage liver disease at the end of life","volume":"15","author":"Patel","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.08.003_bib25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/bmjspcare-2015-000923","article-title":"Palliative care in patients with liver cirrhosis: it is the time to deal with the burden","volume":"5","author":"Lisotti","year":"2015","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.jceh.2022.08.003_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11894-015-0440-6","article-title":"Palliative care for patients with end-stage liver disease","volume":"17","author":"Larson","year":"2015","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jceh.2022.08.003_bib27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jpainsymman.2011.10.018","article-title":"Changing end-of-life care practice for liver transplant service patients: structured palliative care intervention in the surgical intensive care unit","volume":"44","author":"Lamba","year":"2012","journal-title":"J\u00a0Pain Symptom Manag"},{"key":"10.1016\/j.jceh.2022.08.003_bib28","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/lt.25434","article-title":"Current knowledge, barriers to implementation, and future directions in palliative care for end-stage liver disease","volume":"25","author":"Fricker","year":"2019","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.08.003_bib29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/liv.13620","article-title":"Palliative care in decompensated cirrhosis: a review","volume":"38","author":"Langberg","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.08.003_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0269216318807051","article-title":"Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis","volume":"33","author":"Peng","year":"2019","journal-title":"Palliat Med"},{"issue":"1","key":"10.1016\/j.jceh.2022.08.003_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jpainsymman.2018.03.001","article-title":"Psychiatric comorbidity, health-related quality of life, and mental health service utilization among patients awaiting liver transplant","volume":"56","author":"Saracino","year":"2018","journal-title":"J\u00a0Pain Symptom Manag"},{"key":"10.1016\/j.jceh.2022.08.003_bib32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11606-009-0981-1","article-title":"Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference","volume":"24","author":"Krebs","year":"2009","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jceh.2022.08.003_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11901-018-0389-7","article-title":"The assessment and management of pain in cirrhosis","volume":"17","author":"Klinge","year":"2018","journal-title":"Curr Hepat Rep"},{"key":"10.1016\/j.jceh.2022.08.003_bib34","series-title":"Pain Management and Palliative Care","article-title":"Pain management in patients with hepatic impairment","author":"Ehrlich","year":"2015"},{"key":"10.1016\/j.jceh.2022.08.003_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cld.711","article-title":"Pain management in patients with cirrhosis","volume":"11","author":"Rakoski","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.08.003_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/apt.12827","article-title":"Systematic review: the treatment of muscle cramps in patients with cirrhosis","volume":"40","author":"Vidot","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.08.003_bib37","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2010-03-259325","article-title":"How I treat autoimmune hemolytic anemias in adults","volume":"116","author":"Lechner","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jceh.2022.08.003_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cld.516","article-title":"Evaluation and management of insomnia, muscle cramps, fatigue, and itching in cirrhotic patients","volume":"7","author":"Moore","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.08.003_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/apt.16831","article-title":"Review article: current and emerging therapies for the management of cirrhosis and its complications","author":"Tapper","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.08.003_bib40","article-title":"Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trial","author":"Jagdish","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2022.08.003_bib41","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jhep.2016.06.007","article-title":"Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: a randomised controlled trial","volume":"65","author":"Sinclair","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.08.003_bib42","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1007\/s10620-019-5457-5","article-title":"Treatment of fatigue in primary biliary cholangitis: a systematic review and meta-analysis","volume":"64","author":"Lee","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.08.003_bib43","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/hep.31270","article-title":"Sodium-glucose cotransporter 2 inhibitors ameliorate ascites and peripheral Edema in patients with cirrhosis and diabetes","volume":"72","author":"Montalvo-Gordon","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.08.003_bib44","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1572-0241.2000.01980.x","article-title":"Treatment of mastalgia with tamoxifen in male patients with liver cirrhosis: a randomized crossover study","volume":"95","author":"Li","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.08.003_bib45","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.3748\/wjg.v26.i37.5561","article-title":"Transjugular intrahepatic portosystemic shunt in cirrhosis: an exhaustive critical update","volume":"26","author":"Rajesh","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.08.003_bib46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/apt.15802","article-title":"Randomised clinical trial: palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis","volume":"52","author":"Macken","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.08.003_bib47","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s11136-018-1813-8","article-title":"Patients with refractory ascites treated with alfapump\u00ae system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study","volume":"27","author":"Stepanova","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jceh.2022.08.003_bib48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12876-022-02173-5","article-title":"Consensus care recommendations for alfapump\u00ae in cirrhotic patients with refractory or recurrent ascites","volume":"22","author":"Aagaard","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2022.08.003_bib49","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1177\/2050640620938525","article-title":"Transjugular intrahepatic portosystemic shunt and\u00a0alfapump\u00ae system for refractory ascites in liver cirrhosis: outcomes and complications","volume":"8","author":"Will","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.jceh.2022.08.003_bib50","article-title":"Beta-blockers in cirrhosis: evidence-based indications and limitations","volume":"2","author":"Rodrigues","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jceh.2022.08.003_bib51","article-title":"Friend or foe? Spontaneous portosystemic shunts in cirrhosis-current understanding and future prospects","volume":"2021","author":"Rajesh","year":"2021","journal-title":"Chin J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.08.003_bib52","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American association for the study of liver diseases","volume":"74","author":"Lai","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.08.003_bib53","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A\u00a0randomized trial of albumin infusions in hospitalized patients with cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2022.08.003_bib54","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2022.08.003_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2021.12.016","article-title":"Gut microbiome and alcohol-associated liver disease","author":"Philips","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322004546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322004546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:08:56Z","timestamp":1760854136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688322004546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0973688322004546"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2022.08.003","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palliative Care for Patients with End-Stage Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2022.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}